enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.760
+0.120 (7.32%)
At close: May 26, 2026, 4:00 PM EDT
1.710
-0.050 (-2.84%)
After-hours: May 26, 2026, 7:28 PM EDT
enGene Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $9 → $2 | Hold | Maintains | $9 → $2 | +13.64% | May 14, 2026 |
| Leerink Partners | Leerink Partners | Hold Downgrades $2 | Hold | Downgrades | $2 | +13.64% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 → $6 | Buy | Reiterates | $25 → $6 | +240.91% | May 8, 2026 |
| Oppenheimer | Oppenheimer | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 8, 2026 |
| Raymond James | Raymond James | Buy Maintains $27 → $4 | Buy | Maintains | $27 → $4 | +127.27% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Hold Downgrades $7 → $4 | Hold | Downgrades | $7 → $4 | +127.27% | May 8, 2026 |
| Citizens JMP | Citizens JMP | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 8, 2026 |
| Wells Fargo | Wells Fargo | Hold Downgrades $25 → $2 | Hold | Downgrades | $25 → $2 | +13.64% | May 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.